Needham Maintains Buy on Hologic, Raises Price Target to $90
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson maintains a Buy rating on Hologic (NASDAQ:HOLX) and raises the price target from $83 to $90.
February 02, 2024 | 11:01 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham analyst Mike Matson maintains a Buy rating on Hologic and raises the price target from $83 to $90.
The increase in the price target by a reputable analyst suggests a positive outlook on Hologic's future performance, likely leading to increased investor confidence and potentially driving the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100